Phibro Animal Health (NASDAQ:PAHC) Shares Down 3.9%

Phibro Animal Health Co. (NASDAQ:PAHCGet Free Report) traded down 3.9% during trading on Friday . The company traded as low as $16.45 and last traded at $16.47. 11,710 shares traded hands during mid-day trading, a decline of 92% from the average session volume of 143,369 shares. The stock had previously closed at $17.14.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the company. Barclays increased their target price on Phibro Animal Health from $10.00 to $13.00 and gave the stock an “underweight” rating in a research note on Friday, May 10th. StockNews.com raised Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Tuesday, April 9th. Two analysts have rated the stock with a sell rating, one has issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $14.75.

Get Our Latest Research Report on PAHC

Phibro Animal Health Stock Performance

The stock has a market capitalization of $674.73 million, a P/E ratio of 51.75, a P/E/G ratio of 4.49 and a beta of 0.57. The company has a quick ratio of 1.67, a current ratio of 3.16 and a debt-to-equity ratio of 1.69. The business has a fifty day moving average price of $17.41 and a 200-day moving average price of $13.96.

Phibro Animal Health (NASDAQ:PAHCGet Free Report) last announced its quarterly earnings results on Wednesday, May 8th. The company reported $0.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.02. The firm had revenue of $263.20 million for the quarter, compared to the consensus estimate of $251.82 million. Phibro Animal Health had a return on equity of 17.11% and a net margin of 1.32%. On average, sell-side analysts expect that Phibro Animal Health Co. will post 1.13 EPS for the current year.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, June 26th. Stockholders of record on Wednesday, June 5th were issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.88%. The ex-dividend date of this dividend was Wednesday, June 5th. Phibro Animal Health’s payout ratio is currently 150.00%.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Trexquant Investment LP lifted its holdings in Phibro Animal Health by 143.6% in the third quarter. Trexquant Investment LP now owns 35,872 shares of the company’s stock valued at $458,000 after acquiring an additional 21,147 shares during the period. BNP Paribas Financial Markets increased its position in Phibro Animal Health by 290.2% in the fourth quarter. BNP Paribas Financial Markets now owns 73,287 shares of the company’s stock worth $849,000 after buying an additional 54,506 shares in the last quarter. China Universal Asset Management Co. Ltd. increased its position in Phibro Animal Health by 358.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 2,357 shares of the company’s stock worth $27,000 after buying an additional 1,843 shares in the last quarter. Louisiana State Employees Retirement System purchased a new stake in Phibro Animal Health in the fourth quarter worth about $118,000. Finally, Wellington Management Group LLP increased its position in Phibro Animal Health by 165.9% in the fourth quarter. Wellington Management Group LLP now owns 164,764 shares of the company’s stock worth $1,908,000 after buying an additional 102,793 shares in the last quarter. Institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

(Get Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Further Reading

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.